SlideShare a Scribd company logo
Septic shock – Interactive Case
with recommendations
Dr.Vitrag Shah
MD Medicine, FNB Critical Care Medicine, EDIC
Consultant Physician and Chief Intensivist
Kiran Hospital, Surat
Clinical Decision Making
In rapidly developing clinical sciences
Concepts change
Procedures change
Technological evolution occurs
Up-to-date knowledge will benefit patients
Point to be discussed
1. Sepsis 1 to Sepsis 3 – Definition
2. Sepsis bundles
3. Interactive case
4. SSC 2016 recommendations on
 Antibiotic, PCT
 Fluid
 Vasopressor
 Nutrition
 Others
5. Marik Protocol
SEPSIS - 1
1.Temperature >38°C or <36°C;
2.Heart rate >90 beats per minute;
3.Respiratory rate >20 breaths per minute or PaCO2 <32 mmHg;
and
4.White blood cell count >12,000/cu mm, <4,000/cu mm, or >10%
immature (band) forms.
SIRS
Sepsis
Severe sepsis
Septic shock
Two or more of the SIRS criteria plus infection
sepsis associated with organ dysfunction,
hypoperfusion, or hypotension
sepsis-induced hypotension despite adequate fluid resuscitation
along with the presence of perfusion abnormalities causing organ
dysfunction that may include lactic acidosis, oliguria, or an acute
alteration in mental status
SEPSIS -2
Concerns with the previous sepsis definition…
The Problem with SIRS
Inflammation and related pathways take center stage
Adapted from: Bone RC et al. Chest. 1992;101:1644-55.
Opal SM et al. Crit Care Med. 2000;28:S81-2.
SEPSIS -3
SEPSIS -3
life-threatening
organ dysfunction caused
by
dysregulated host response
to infection
Sepsis
Severe sepsis
Septic
shock
Suspected or
documented
infection and an
acute increase of
≥2 SOFA points
Subset of sepsis in which
underlying circulatory and
cellular/metabolic
abnormalities are profound
enough to substantially
increase mortality
Despite adequate fluid
resuscitation
vasopressor therapy
needed to elevate MAP
≥65 mmHg and
lactate >2 mmol L−1
1.Altered mental status (GCS
score <15)
2.Systolic blood pressure
<100 mmHg
3.Respiratory rate >22/min
qSOFA
If 2/3 of these 3 criteria are positive, the qSOFA
would be positive!
MANAGEMENT OF
SEPSIS
CASE HISTORY
• 64 year old female
• H/O Ca tongue (Operated in 2018), completed
Chemotherapy & Radiotherapy (Last RT 1
month back)
• C/O constipation
• C/O Abdominal distension & pain since
yesterday
• C/O fever, low grade & breahing difficulty and
decreased urine output since today morning
• Presented to Our Hospital ER at 2:15PM
Physical Examination - 2:15 PM
• GCS 15/15
• T - 98.6 F
• HR - 100/min
• RR - 22/min
• RR - 90/60 mmhg
• SPO2 - 99% on room Air
• P/A - Soft, Distended, Tenderness - Diffuse
• RS, CVS, CNS - Clinically NAD
Diagnosis?
SSC BUNDLES
(SSC GUIDELINES-2012)
REVISED SEPSIS BUNDLES
(SSC 2015 UPDATE)
REVISED SEPSIS BUNDLES
(SSC 2015 UPDATE)
Surviving Sepsis Campaign : 1 HOUR
BUNDLE (2018)
• Measure lactate level*
• Obtain blood cultures before administering antibiotics.
• Administer broad-spectrum antibiotics.
• Begin rapid administration of 30mL/kg crystalloid for hypotension or lactate level ≥
4 ​mmol/L.
• Apply vasopressors if hypotensive during or after fluid resuscitation to maintain
MAP ≥ 65 mm Hg.
• * Remeasure lactate if initial lactate is elevated (> 2 mmol/L).
Primary Investigations (2-3PM)
• Chest X-Ray - Gas under diaphragm
• PreopMajor, ABG & one set paired aerobic Blood C/S sent
• RBS - 77mg%
• ABG
– pH 7.16
– PO2 113 on room air
– PCO2 13.5
– HCO3 4.7
– Lactate 18
– Na/K/Cl 134/3.8/107
– Hb/HCT 12.8/39.5
Antibiotic
Primary Treatment BY 3:30PM
• Inj.CEFOSULBACTAM 3GM IV STAT
• INJ.METRONIDAZOLE 500MG IV STAT
• INJ 25% D/W IV STAT
• INJ NS 1 LITER OVER ONE HOUR
• Foley's Catheterization
Fluid
INITIAL RESUSCITATION
PHYSICAL EXAMINATION - 4PM
• GCS 15/15
• HR 120/MIN
• RR 26/MIN
• BP 90/50MMHG ( MAP = 63mmhg)
Hemodynamic
assessment
2D ECHO & LUNG USG
• 2D ECHO SCREEN
– EF : GOOD, RA,RV - NORMAL, IVC - 0.9CM
>50% COLLAPSING
• LUNG USG
– NO B-LINES, SLIDING PRESENT
EGDT
Reduced the absolute risk of
in-hospital mortality by 16 %
We recommend the protocolized, quantitative
resuscitation of patients with sepsis- induced
tissue hypoperfusion
During the first 6 hrs , the goals of initial
resuscitation
a) CVP 8–12 mm Hg
b) MAP ≥ 65 mm Hg
c) Urine output ≥ 0.5 ml/kg/hr
d) Superior vena cava oxygenation saturation
(Scvo2) or mixed venous oxygen saturation
(SvO2) 70% or 65%, respectively
EGDT DRAWBACKS
An arbitrary CVP as surrogate of fluid status
MAP and urine output as surrogate for
organ perfusion
As marker for O2
utilization
Blood transfusions and ionotropes based on Sc
Decision to give fluid should be based on :
• Presence of acute circulatory failure
• Presence of preload responsiveness
• Minimal risk of administering fluid
Functional Hemodynamic Monitoring
Assessing preload responsiveness
• Variations in arterial pulse pressure, systolic pressure
• Passive leg raising
• End Expiratory Occlusion Test (EEOT)
• Aortic flow variation (TED)
• Echocardiography – IVC and SVC diameter changes
• Mini Fluid Challenge
• End-tidal carbon dioxide
• Non invasive methods - pulse oximeter pleth signal variability
Assess Fluid Tolerance
• Echocardiography – EF, Diastolic function
• Lung Ultrasound - B-Lines
1 Fluid challenge not required if CVP is high
2 Fluid challenge not done in pulmonary edema
• Hypovolemia due to extravasation into lungs
• If shock, fluid challenge will improve blood pressure
3 No fluid challenge since patient has already received 1
litre of fluid in last 1 hour
4 Must continue fluid challenge since CVP is low
Misconceptions in Fluid Challenge
RELATIVE EFFECTS OF COMMON VASOACTIVE
MEDICATIONS ON ADRENERGIC RECEPTORS
AGENT (typical dosages) ß-1 ß-2 α-1
Isoproterenol (2-10 ug/min) +++++ +++++ 0
NE (0.01-3 ug/kg/min) +++ ++ +++++
Epinephrine
(Infusion: 0.01 to 0.10 ug/kg/min)
++++ +++ +++++
Phenylephrine
(Infusion: 0.4 to 9.1 ug/kg/min)
0 0 +++++
Dopamine
(2.0 to 20 ug /kg/min, max 50 ug/kg/min )
++++ ++ +++
Dobutamine
(2.0 to 20 ug /kg/min, max 40 ug/kg/min )
+++++ +++ +
- Overgaard CB. Circulation 2008
Antibiotics
• We suggest empiric combination therapy
(using at least two antibiotics of different
antimicrobial classes) aimed at the most
likely bacterial pathogen(s) & having good
concentration at suspected site of
infection for the initial management of
septic shock.
– (Weak recommendation; low quality of
evidence)
Antibiotics
• We suggest that combination therapy not be
routinely used for on-going treatment of
most other serious infections, including
bacteremia and sepsis without shock.
– (Weak recommendation; low quality of
evidence).
• We recommend against combination therapy
for the routine treatment of neutropenic
sepsis/bacteremia.
– (Strong recommendation; moderate
quality of evidence).
Know your local organisms & sensitivity.
Because that determines your antibiotic.
Further Treatment (4-5PM)
• RL 500CC + 500CC BOLUS OVER 1 HOUR
• Inj HYDROCORTISONE 200MG IV STAT
• INJ ASCORBIC ACID 1GM IV STAT
• INJ MEROPENAM 2GM IV STAT
(CEFOSULBACTAM STOPPED)
• NORADRENALINE INFUSION
• CENTRAL & ARTERIAL LINE INSERTION
A target of no more than 6 to 12 hours after
diagnosis appears to be sufficient for most
cases
FURTHER TREATMENT (6PM)
• After primary resuscitation, patient shifted to
OT by 6:15pm
• Sigmoid diverticular perforation and peritonitis
- Exploratory Laprotomy & Hartman Procedure
done, Pus C/S sent intraop.
• Patient shifted to ICU with Nasotracheal &
Nasogastric tube and drains in situ at 9:00 PM
Further course in ICU (POD 0-3)
• PATIENT SEDATED
• HR 100/MIN, BP 100/70 WITH NORAD ( 8MG/50ML)
@ 5ML/HR
• ON CONTROLLED MODE OF VENTILATOR
• 2.5 LITRE I/P & 700ML URINE OUTPUT ON ARRIVAL
• 40-50ML/HR URINE AFTER ICU ADMISSION
• Weaning from ventilator started from POD1,
vasopressors tappered
• Decreased urine output on POD1 – 5% Albumin
100ml given in addition to manitainance IV fluid
POD-2 to POD-3
• On T-piece for 24 hours on POD2, passing good
urine, vasopressors tappered and stopped.
• Extubated on POD 3
• Pus C/S - E.Coli - Sensitive to BL-BLI,
Quinolones, Aminoglycosides, Carbapenams,
Tigecycline, Fosfomycin, TMP-SMZ,
Chloramphenicol
• Blood C/S - Negative
Antimicrobial Therapy
Antibiotic Stewardship
 We recommend that empiric antimicrobial therapy be
narrowed once pathogen identification and sensitivities are
established and/or adequate clinical improvement is noted.
 (BPS)
 We suggest that an antimicrobial treatment duration of 7-10
days is adequate for most serious infections associated with
sepsis and septic shock.
 (Weak recommendation; low quality of evidence)
 We recommend daily assessment for de-escalation of
antimicrobial therapy in patients with sepsis and septic
shock.
 (BPS)
 We recommend that dosing strategies of antimicrobials be
optimized based on accepted pk/pd principles and specific
drug properties in patients with sepsis or septic shock
 (BPS)
Role of Procalcitonin
POD4 onwards
• Vital stable
• Mobilized
• Maintainance IV fluid as per electrolyte & daily
intake output.
• Shifted to ward
• Meropenam continued for total 8 days
• Stoma started functioning & orally liquid diet
started from POD4.
• Soft diet started from POD5.
• Patient discharged from ward on POD9.
Nutrition
 www.survivingsepsis.org
 Malbrain, M.L.N.G., Regenmortel, N., Saugel, B. et al. Principles of fluid management and stewardship in
septic shock: it is time to consider the four D’s and the four phases of fluid therapy. Ann. Intensive
Care 8, 66 (2018)
 LIFTL : https://lifeinthefastlane.com/
 UpToDate : www.uptodate.com
Questions…….?
THANK
YOU

More Related Content

What's hot

Sepsis
SepsisSepsis
Surviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSurviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines Updated
Sun Yai-Cheng
 
VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?
Sun Yai-Cheng
 
Severe sepsis and septic shock :evaluation and management
Severe sepsis and septic shock :evaluation and managementSevere sepsis and septic shock :evaluation and management
Severe sepsis and septic shock :evaluation and management
Md Shahid Iqubal
 
Hypokalemia in ICU
Hypokalemia in ICUHypokalemia in ICU
Hypokalemia in ICU
Muhammad Asim Rana
 
Mechanical Ventilation of Patients with COPD and Asthma
Mechanical Ventilation of Patients with COPD and AsthmaMechanical Ventilation of Patients with COPD and Asthma
Mechanical Ventilation of Patients with COPD and Asthma
Dr.Mahmoud Abbas
 
CURRENT INTERNATIONAL GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS AND SEPTIC S...
CURRENT INTERNATIONAL GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS AND SEPTIC S...CURRENT INTERNATIONAL GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS AND SEPTIC S...
CURRENT INTERNATIONAL GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS AND SEPTIC S...
Bassel Ericsoussi, MD
 
Septic shock
Septic shockSeptic shock
Septic shock
abdullah alzahrani
 
Surviving sepsis campaign highlights 2016
Surviving sepsis campaign  highlights 2016Surviving sepsis campaign  highlights 2016
Surviving sepsis campaign highlights 2016
Sekar Loganathan
 
Fluid management in ICU
Fluid management in ICUFluid management in ICU
Fluid management in ICU
Ahmed Elsaid
 
Management of sepsis
Management of sepsis Management of sepsis
Management of sepsis
Ankur Gupta
 
Fluids in Intensive Care
Fluids in Intensive Care Fluids in Intensive Care
Fluids in Intensive Care
Vineel Bezawada
 
Sepsis Updates
Sepsis UpdatesSepsis Updates
Sepsis Updates
Spectrum Health System
 
Sepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis GuidelinesSepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis Guidelines
Noorulhaque Shaikh
 
Sepsis: ED and Trauma symposium
Sepsis: ED and Trauma symposiumSepsis: ED and Trauma symposium
Sepsis: ED and Trauma symposium
UFJaxEMS
 
Septic shock management (1)
Septic shock management (1)Septic shock management (1)
Septic shock management (1)
shashank agrawal
 
New modes of mechanical ventilation TRC
New modes of mechanical ventilation TRCNew modes of mechanical ventilation TRC
New modes of mechanical ventilation TRCchandra talur
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest update
Ramadan Arafa
 
Sepsis and septic shock guidelines
Sepsis  and septic shock guidelinesSepsis  and septic shock guidelines
Sepsis and septic shock guidelines
MEEQAT HOSPITAL
 

What's hot (20)

Sepsis
SepsisSepsis
Sepsis
 
Surviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSurviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines Updated
 
VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?
 
Sepsis And Septic Shock
Sepsis And Septic ShockSepsis And Septic Shock
Sepsis And Septic Shock
 
Severe sepsis and septic shock :evaluation and management
Severe sepsis and septic shock :evaluation and managementSevere sepsis and septic shock :evaluation and management
Severe sepsis and septic shock :evaluation and management
 
Hypokalemia in ICU
Hypokalemia in ICUHypokalemia in ICU
Hypokalemia in ICU
 
Mechanical Ventilation of Patients with COPD and Asthma
Mechanical Ventilation of Patients with COPD and AsthmaMechanical Ventilation of Patients with COPD and Asthma
Mechanical Ventilation of Patients with COPD and Asthma
 
CURRENT INTERNATIONAL GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS AND SEPTIC S...
CURRENT INTERNATIONAL GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS AND SEPTIC S...CURRENT INTERNATIONAL GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS AND SEPTIC S...
CURRENT INTERNATIONAL GUIDELINES FOR MANAGEMENT OF SEVERE SEPSIS AND SEPTIC S...
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Surviving sepsis campaign highlights 2016
Surviving sepsis campaign  highlights 2016Surviving sepsis campaign  highlights 2016
Surviving sepsis campaign highlights 2016
 
Fluid management in ICU
Fluid management in ICUFluid management in ICU
Fluid management in ICU
 
Management of sepsis
Management of sepsis Management of sepsis
Management of sepsis
 
Fluids in Intensive Care
Fluids in Intensive Care Fluids in Intensive Care
Fluids in Intensive Care
 
Sepsis Updates
Sepsis UpdatesSepsis Updates
Sepsis Updates
 
Sepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis GuidelinesSepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis Guidelines
 
Sepsis: ED and Trauma symposium
Sepsis: ED and Trauma symposiumSepsis: ED and Trauma symposium
Sepsis: ED and Trauma symposium
 
Septic shock management (1)
Septic shock management (1)Septic shock management (1)
Septic shock management (1)
 
New modes of mechanical ventilation TRC
New modes of mechanical ventilation TRCNew modes of mechanical ventilation TRC
New modes of mechanical ventilation TRC
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest update
 
Sepsis and septic shock guidelines
Sepsis  and septic shock guidelinesSepsis  and septic shock guidelines
Sepsis and septic shock guidelines
 

Similar to Perforation - Interactive case on Septic Shock

Surviving sepsis Guidelines 2012
Surviving sepsis Guidelines 2012Surviving sepsis Guidelines 2012
Surviving sepsis Guidelines 2012Sourabh Pathak
 
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptxSEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
mainhamza411
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
mahadev deuja
 
What is new in sepsis
What is new in sepsisWhat is new in sepsis
What is new in sepsis
Kamal Bharathi
 
Room a b01. mcgee-new sepsis_(en)
Room a b01. mcgee-new sepsis_(en)Room a b01. mcgee-new sepsis_(en)
Room a b01. mcgee-new sepsis_(en)
SoM
 
Dr hamada alsedawy sepsis and aki
Dr hamada alsedawy   sepsis and akiDr hamada alsedawy   sepsis and aki
Dr hamada alsedawy sepsis and aki
FarragBahbah
 
Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedKit GenSx
 
management of sepsis management of sepsis .pptx
management of sepsis management of sepsis .pptxmanagement of sepsis management of sepsis .pptx
management of sepsis management of sepsis .pptx
valkad69
 
Sepsis 4 a to z(u) in sepsis management
Sepsis 4 a to z(u) in sepsis managementSepsis 4 a to z(u) in sepsis management
Sepsis 4 a to z(u) in sepsis management
ashish ranjan
 
Sepsis 2009 update final
Sepsis 2009 update finalSepsis 2009 update final
Sepsis 2009 update final
Troy Pennington
 
Managing sepsis and septic shock 1
Managing sepsis and septic shock 1Managing sepsis and septic shock 1
Managing sepsis and septic shock 1
charul jakhwal
 
Approach to Management of Fever & Sepsis (2) copy.pptx
Approach to Management of Fever & Sepsis (2) copy.pptxApproach to Management of Fever & Sepsis (2) copy.pptx
Approach to Management of Fever & Sepsis (2) copy.pptx
HarryArwin1
 
IV%20FLUIDS.pptx
IV%20FLUIDS.pptxIV%20FLUIDS.pptx
IV%20FLUIDS.pptx
ArunHM3
 
Sepsis &amp; septic shock an updated management
Sepsis &amp; septic shock an updated managementSepsis &amp; septic shock an updated management
Sepsis &amp; septic shock an updated management
ahad80a
 
SURVIVING SEPSIS CAMPAIGN- 2012 to 2016
SURVIVING SEPSIS CAMPAIGN- 2012 to 2016SURVIVING SEPSIS CAMPAIGN- 2012 to 2016
SURVIVING SEPSIS CAMPAIGN- 2012 to 2016
Rahul Goel
 
Septic shock management
Septic shock managementSeptic shock management
Septic shock management
drnabina
 
Sepsis
SepsisSepsis
Surviving sepsis guidelines
Surviving sepsis guidelinesSurviving sepsis guidelines
Surviving sepsis guidelines
Richa Kumar
 

Similar to Perforation - Interactive case on Septic Shock (20)

Surviving sepsis Guidelines 2012
Surviving sepsis Guidelines 2012Surviving sepsis Guidelines 2012
Surviving sepsis Guidelines 2012
 
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptxSEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
What is new in sepsis
What is new in sepsisWhat is new in sepsis
What is new in sepsis
 
Room a b01. mcgee-new sepsis_(en)
Room a b01. mcgee-new sepsis_(en)Room a b01. mcgee-new sepsis_(en)
Room a b01. mcgee-new sepsis_(en)
 
Dr hamada alsedawy sepsis and aki
Dr hamada alsedawy   sepsis and akiDr hamada alsedawy   sepsis and aki
Dr hamada alsedawy sepsis and aki
 
Copy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revisedCopy (2) of sepsis present เซกา revised
Copy (2) of sepsis present เซกา revised
 
management of sepsis management of sepsis .pptx
management of sepsis management of sepsis .pptxmanagement of sepsis management of sepsis .pptx
management of sepsis management of sepsis .pptx
 
Sepsis 4 a to z(u) in sepsis management
Sepsis 4 a to z(u) in sepsis managementSepsis 4 a to z(u) in sepsis management
Sepsis 4 a to z(u) in sepsis management
 
Sepsis 2009 update final
Sepsis 2009 update finalSepsis 2009 update final
Sepsis 2009 update final
 
Managing sepsis and septic shock 1
Managing sepsis and septic shock 1Managing sepsis and septic shock 1
Managing sepsis and septic shock 1
 
Approach to Management of Fever & Sepsis (2) copy.pptx
Approach to Management of Fever & Sepsis (2) copy.pptxApproach to Management of Fever & Sepsis (2) copy.pptx
Approach to Management of Fever & Sepsis (2) copy.pptx
 
IV%20FLUIDS.pptx
IV%20FLUIDS.pptxIV%20FLUIDS.pptx
IV%20FLUIDS.pptx
 
Sepsis &amp; septic shock an updated management
Sepsis &amp; septic shock an updated managementSepsis &amp; septic shock an updated management
Sepsis &amp; septic shock an updated management
 
SURVIVING SEPSIS CAMPAIGN- 2012 to 2016
SURVIVING SEPSIS CAMPAIGN- 2012 to 2016SURVIVING SEPSIS CAMPAIGN- 2012 to 2016
SURVIVING SEPSIS CAMPAIGN- 2012 to 2016
 
Bundle of sepsis
Bundle of sepsisBundle of sepsis
Bundle of sepsis
 
Septic shock management
Septic shock managementSeptic shock management
Septic shock management
 
CME: Management of Severe Sepsis & Septic Shock
CME: Management of Severe Sepsis & Septic ShockCME: Management of Severe Sepsis & Septic Shock
CME: Management of Severe Sepsis & Septic Shock
 
Sepsis
SepsisSepsis
Sepsis
 
Surviving sepsis guidelines
Surviving sepsis guidelinesSurviving sepsis guidelines
Surviving sepsis guidelines
 

More from Vitrag Shah

Managing MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICUManaging MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICU
Vitrag Shah
 
DUAL PNEUMONIA CASE
DUAL PNEUMONIA CASEDUAL PNEUMONIA CASE
DUAL PNEUMONIA CASE
Vitrag Shah
 
Preventable ICU admissions at community level - Interactive Cases
Preventable ICU admissions at community level - Interactive CasesPreventable ICU admissions at community level - Interactive Cases
Preventable ICU admissions at community level - Interactive Cases
Vitrag Shah
 
FEVER IN TRAUMA - Final.pptx
FEVER IN TRAUMA - Final.pptxFEVER IN TRAUMA - Final.pptx
FEVER IN TRAUMA - Final.pptx
Vitrag Shah
 
Optimizing Antibiotic use in ICU using PK-PD principles
Optimizing Antibiotic use in ICU using PK-PD principlesOptimizing Antibiotic use in ICU using PK-PD principles
Optimizing Antibiotic use in ICU using PK-PD principles
Vitrag Shah
 
Ventilatory management of Acute Hypercapnic Respiratory Failure
Ventilatory management of Acute Hypercapnic Respiratory FailureVentilatory management of Acute Hypercapnic Respiratory Failure
Ventilatory management of Acute Hypercapnic Respiratory Failure
Vitrag Shah
 
Ventilatory management in obstructive airway diseases
Ventilatory management in obstructive airway diseasesVentilatory management in obstructive airway diseases
Ventilatory management in obstructive airway diseases
Vitrag Shah
 
H1N1 ARDS Case Presentation
H1N1 ARDS Case PresentationH1N1 ARDS Case Presentation
H1N1 ARDS Case Presentation
Vitrag Shah
 
ARDS - Diagnosis and Management
ARDS - Diagnosis and ManagementARDS - Diagnosis and Management
ARDS - Diagnosis and Management
Vitrag Shah
 
Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
Vitrag Shah
 
Involuntary movements
Involuntary movementsInvoluntary movements
Involuntary movements
Vitrag Shah
 
Tetanus Presentation
Tetanus PresentationTetanus Presentation
Tetanus Presentation
Vitrag Shah
 
Chronic Obstructive Lung Disease
Chronic Obstructive Lung DiseaseChronic Obstructive Lung Disease
Chronic Obstructive Lung Disease
Vitrag Shah
 
Early management of ACS
Early management of ACSEarly management of ACS
Early management of ACS
Vitrag Shah
 
Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
Vitrag Shah
 
Acid-Base Disorders
Acid-Base DisordersAcid-Base Disorders
Acid-Base Disorders
Vitrag Shah
 
Speech disorders
Speech disordersSpeech disorders
Speech disorders
Vitrag Shah
 
Heart sounds and murmur
Heart sounds and murmurHeart sounds and murmur
Heart sounds and murmur
Vitrag Shah
 

More from Vitrag Shah (18)

Managing MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICUManaging MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICU
 
DUAL PNEUMONIA CASE
DUAL PNEUMONIA CASEDUAL PNEUMONIA CASE
DUAL PNEUMONIA CASE
 
Preventable ICU admissions at community level - Interactive Cases
Preventable ICU admissions at community level - Interactive CasesPreventable ICU admissions at community level - Interactive Cases
Preventable ICU admissions at community level - Interactive Cases
 
FEVER IN TRAUMA - Final.pptx
FEVER IN TRAUMA - Final.pptxFEVER IN TRAUMA - Final.pptx
FEVER IN TRAUMA - Final.pptx
 
Optimizing Antibiotic use in ICU using PK-PD principles
Optimizing Antibiotic use in ICU using PK-PD principlesOptimizing Antibiotic use in ICU using PK-PD principles
Optimizing Antibiotic use in ICU using PK-PD principles
 
Ventilatory management of Acute Hypercapnic Respiratory Failure
Ventilatory management of Acute Hypercapnic Respiratory FailureVentilatory management of Acute Hypercapnic Respiratory Failure
Ventilatory management of Acute Hypercapnic Respiratory Failure
 
Ventilatory management in obstructive airway diseases
Ventilatory management in obstructive airway diseasesVentilatory management in obstructive airway diseases
Ventilatory management in obstructive airway diseases
 
H1N1 ARDS Case Presentation
H1N1 ARDS Case PresentationH1N1 ARDS Case Presentation
H1N1 ARDS Case Presentation
 
ARDS - Diagnosis and Management
ARDS - Diagnosis and ManagementARDS - Diagnosis and Management
ARDS - Diagnosis and Management
 
Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
 
Involuntary movements
Involuntary movementsInvoluntary movements
Involuntary movements
 
Tetanus Presentation
Tetanus PresentationTetanus Presentation
Tetanus Presentation
 
Chronic Obstructive Lung Disease
Chronic Obstructive Lung DiseaseChronic Obstructive Lung Disease
Chronic Obstructive Lung Disease
 
Early management of ACS
Early management of ACSEarly management of ACS
Early management of ACS
 
Hypothyroidism
HypothyroidismHypothyroidism
Hypothyroidism
 
Acid-Base Disorders
Acid-Base DisordersAcid-Base Disorders
Acid-Base Disorders
 
Speech disorders
Speech disordersSpeech disorders
Speech disorders
 
Heart sounds and murmur
Heart sounds and murmurHeart sounds and murmur
Heart sounds and murmur
 

Recently uploaded

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 

Recently uploaded (20)

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 

Perforation - Interactive case on Septic Shock

  • 1. Septic shock – Interactive Case with recommendations Dr.Vitrag Shah MD Medicine, FNB Critical Care Medicine, EDIC Consultant Physician and Chief Intensivist Kiran Hospital, Surat
  • 2. Clinical Decision Making In rapidly developing clinical sciences Concepts change Procedures change Technological evolution occurs Up-to-date knowledge will benefit patients
  • 3. Point to be discussed 1. Sepsis 1 to Sepsis 3 – Definition 2. Sepsis bundles 3. Interactive case 4. SSC 2016 recommendations on  Antibiotic, PCT  Fluid  Vasopressor  Nutrition  Others 5. Marik Protocol
  • 4.
  • 5. SEPSIS - 1 1.Temperature >38°C or <36°C; 2.Heart rate >90 beats per minute; 3.Respiratory rate >20 breaths per minute or PaCO2 <32 mmHg; and 4.White blood cell count >12,000/cu mm, <4,000/cu mm, or >10% immature (band) forms. SIRS Sepsis Severe sepsis Septic shock Two or more of the SIRS criteria plus infection sepsis associated with organ dysfunction, hypoperfusion, or hypotension sepsis-induced hypotension despite adequate fluid resuscitation along with the presence of perfusion abnormalities causing organ dysfunction that may include lactic acidosis, oliguria, or an acute alteration in mental status
  • 7. Concerns with the previous sepsis definition… The Problem with SIRS Inflammation and related pathways take center stage Adapted from: Bone RC et al. Chest. 1992;101:1644-55. Opal SM et al. Crit Care Med. 2000;28:S81-2.
  • 9. SEPSIS -3 life-threatening organ dysfunction caused by dysregulated host response to infection Sepsis Severe sepsis Septic shock Suspected or documented infection and an acute increase of ≥2 SOFA points Subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality Despite adequate fluid resuscitation vasopressor therapy needed to elevate MAP ≥65 mmHg and lactate >2 mmol L−1
  • 10. 1.Altered mental status (GCS score <15) 2.Systolic blood pressure <100 mmHg 3.Respiratory rate >22/min qSOFA If 2/3 of these 3 criteria are positive, the qSOFA would be positive!
  • 11.
  • 12.
  • 14. CASE HISTORY • 64 year old female • H/O Ca tongue (Operated in 2018), completed Chemotherapy & Radiotherapy (Last RT 1 month back) • C/O constipation • C/O Abdominal distension & pain since yesterday • C/O fever, low grade & breahing difficulty and decreased urine output since today morning • Presented to Our Hospital ER at 2:15PM
  • 15. Physical Examination - 2:15 PM • GCS 15/15 • T - 98.6 F • HR - 100/min • RR - 22/min • RR - 90/60 mmhg • SPO2 - 99% on room Air • P/A - Soft, Distended, Tenderness - Diffuse • RS, CVS, CNS - Clinically NAD
  • 20. Surviving Sepsis Campaign : 1 HOUR BUNDLE (2018) • Measure lactate level* • Obtain blood cultures before administering antibiotics. • Administer broad-spectrum antibiotics. • Begin rapid administration of 30mL/kg crystalloid for hypotension or lactate level ≥ 4 ​mmol/L. • Apply vasopressors if hypotensive during or after fluid resuscitation to maintain MAP ≥ 65 mm Hg. • * Remeasure lactate if initial lactate is elevated (> 2 mmol/L).
  • 21. Primary Investigations (2-3PM) • Chest X-Ray - Gas under diaphragm • PreopMajor, ABG & one set paired aerobic Blood C/S sent • RBS - 77mg% • ABG – pH 7.16 – PO2 113 on room air – PCO2 13.5 – HCO3 4.7 – Lactate 18 – Na/K/Cl 134/3.8/107 – Hb/HCT 12.8/39.5
  • 22. Antibiotic Primary Treatment BY 3:30PM • Inj.CEFOSULBACTAM 3GM IV STAT • INJ.METRONIDAZOLE 500MG IV STAT • INJ 25% D/W IV STAT • INJ NS 1 LITER OVER ONE HOUR • Foley's Catheterization Fluid
  • 24.
  • 25. PHYSICAL EXAMINATION - 4PM • GCS 15/15 • HR 120/MIN • RR 26/MIN • BP 90/50MMHG ( MAP = 63mmhg)
  • 26. Hemodynamic assessment 2D ECHO & LUNG USG • 2D ECHO SCREEN – EF : GOOD, RA,RV - NORMAL, IVC - 0.9CM >50% COLLAPSING • LUNG USG – NO B-LINES, SLIDING PRESENT
  • 27.
  • 28. EGDT Reduced the absolute risk of in-hospital mortality by 16 % We recommend the protocolized, quantitative resuscitation of patients with sepsis- induced tissue hypoperfusion During the first 6 hrs , the goals of initial resuscitation a) CVP 8–12 mm Hg b) MAP ≥ 65 mm Hg c) Urine output ≥ 0.5 ml/kg/hr d) Superior vena cava oxygenation saturation (Scvo2) or mixed venous oxygen saturation (SvO2) 70% or 65%, respectively
  • 29. EGDT DRAWBACKS An arbitrary CVP as surrogate of fluid status MAP and urine output as surrogate for organ perfusion As marker for O2 utilization Blood transfusions and ionotropes based on Sc
  • 30. Decision to give fluid should be based on : • Presence of acute circulatory failure • Presence of preload responsiveness • Minimal risk of administering fluid
  • 31. Functional Hemodynamic Monitoring Assessing preload responsiveness • Variations in arterial pulse pressure, systolic pressure • Passive leg raising • End Expiratory Occlusion Test (EEOT) • Aortic flow variation (TED) • Echocardiography – IVC and SVC diameter changes • Mini Fluid Challenge • End-tidal carbon dioxide • Non invasive methods - pulse oximeter pleth signal variability Assess Fluid Tolerance • Echocardiography – EF, Diastolic function • Lung Ultrasound - B-Lines
  • 32.
  • 33. 1 Fluid challenge not required if CVP is high 2 Fluid challenge not done in pulmonary edema • Hypovolemia due to extravasation into lungs • If shock, fluid challenge will improve blood pressure 3 No fluid challenge since patient has already received 1 litre of fluid in last 1 hour 4 Must continue fluid challenge since CVP is low Misconceptions in Fluid Challenge
  • 34.
  • 35. RELATIVE EFFECTS OF COMMON VASOACTIVE MEDICATIONS ON ADRENERGIC RECEPTORS AGENT (typical dosages) ß-1 ß-2 α-1 Isoproterenol (2-10 ug/min) +++++ +++++ 0 NE (0.01-3 ug/kg/min) +++ ++ +++++ Epinephrine (Infusion: 0.01 to 0.10 ug/kg/min) ++++ +++ +++++ Phenylephrine (Infusion: 0.4 to 9.1 ug/kg/min) 0 0 +++++ Dopamine (2.0 to 20 ug /kg/min, max 50 ug/kg/min ) ++++ ++ +++ Dobutamine (2.0 to 20 ug /kg/min, max 40 ug/kg/min ) +++++ +++ + - Overgaard CB. Circulation 2008
  • 36.
  • 37. Antibiotics • We suggest empiric combination therapy (using at least two antibiotics of different antimicrobial classes) aimed at the most likely bacterial pathogen(s) & having good concentration at suspected site of infection for the initial management of septic shock. – (Weak recommendation; low quality of evidence)
  • 38. Antibiotics • We suggest that combination therapy not be routinely used for on-going treatment of most other serious infections, including bacteremia and sepsis without shock. – (Weak recommendation; low quality of evidence). • We recommend against combination therapy for the routine treatment of neutropenic sepsis/bacteremia. – (Strong recommendation; moderate quality of evidence).
  • 39. Know your local organisms & sensitivity. Because that determines your antibiotic.
  • 40. Further Treatment (4-5PM) • RL 500CC + 500CC BOLUS OVER 1 HOUR • Inj HYDROCORTISONE 200MG IV STAT • INJ ASCORBIC ACID 1GM IV STAT • INJ MEROPENAM 2GM IV STAT (CEFOSULBACTAM STOPPED) • NORADRENALINE INFUSION • CENTRAL & ARTERIAL LINE INSERTION
  • 41. A target of no more than 6 to 12 hours after diagnosis appears to be sufficient for most cases
  • 42. FURTHER TREATMENT (6PM) • After primary resuscitation, patient shifted to OT by 6:15pm • Sigmoid diverticular perforation and peritonitis - Exploratory Laprotomy & Hartman Procedure done, Pus C/S sent intraop. • Patient shifted to ICU with Nasotracheal & Nasogastric tube and drains in situ at 9:00 PM
  • 43.
  • 44. Further course in ICU (POD 0-3) • PATIENT SEDATED • HR 100/MIN, BP 100/70 WITH NORAD ( 8MG/50ML) @ 5ML/HR • ON CONTROLLED MODE OF VENTILATOR • 2.5 LITRE I/P & 700ML URINE OUTPUT ON ARRIVAL • 40-50ML/HR URINE AFTER ICU ADMISSION • Weaning from ventilator started from POD1, vasopressors tappered • Decreased urine output on POD1 – 5% Albumin 100ml given in addition to manitainance IV fluid
  • 45.
  • 46. POD-2 to POD-3 • On T-piece for 24 hours on POD2, passing good urine, vasopressors tappered and stopped. • Extubated on POD 3 • Pus C/S - E.Coli - Sensitive to BL-BLI, Quinolones, Aminoglycosides, Carbapenams, Tigecycline, Fosfomycin, TMP-SMZ, Chloramphenicol • Blood C/S - Negative
  • 47. Antimicrobial Therapy Antibiotic Stewardship  We recommend that empiric antimicrobial therapy be narrowed once pathogen identification and sensitivities are established and/or adequate clinical improvement is noted.  (BPS)  We suggest that an antimicrobial treatment duration of 7-10 days is adequate for most serious infections associated with sepsis and septic shock.  (Weak recommendation; low quality of evidence)  We recommend daily assessment for de-escalation of antimicrobial therapy in patients with sepsis and septic shock.  (BPS)  We recommend that dosing strategies of antimicrobials be optimized based on accepted pk/pd principles and specific drug properties in patients with sepsis or septic shock  (BPS)
  • 49. POD4 onwards • Vital stable • Mobilized • Maintainance IV fluid as per electrolyte & daily intake output. • Shifted to ward • Meropenam continued for total 8 days • Stoma started functioning & orally liquid diet started from POD4. • Soft diet started from POD5. • Patient discharged from ward on POD9.
  • 51.
  • 52.
  • 53.
  • 54.  www.survivingsepsis.org  Malbrain, M.L.N.G., Regenmortel, N., Saugel, B. et al. Principles of fluid management and stewardship in septic shock: it is time to consider the four D’s and the four phases of fluid therapy. Ann. Intensive Care 8, 66 (2018)  LIFTL : https://lifeinthefastlane.com/  UpToDate : www.uptodate.com